Close

Novavax Continues Phase 3 Trial of the RSV F Vaccine for Infants via Maternal Immunization and Provides Update on Phase 1/2 Trial of the NanoFlu(TM) Vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. INFY
3. ISRG
4. TSM
5. SNV
6. SPY
7. JWN
8. BX
9. SLB
10. PPG


Go back to Novavax Continues Phase 3 Trial of the RSV F Vaccine for Infants via Maternal Immunization and Provides Update on Phase 1/2 Trial of the NanoFlu(TM) Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 3.89 --0 (-0%)
Previous Close $3.89    52 Week High $9.23 
Open $3.89    52 Week Low $1.16 
Day High $3.89    P/E N/A 
Day Low $3.89    EPS $-0.30 
Volume 25,723       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 3.89 --0 (-0%)
Previous Close $3.89    52 Week High $9.23 
Open $3.89    52 Week Low $1.16 
Day High $3.89    P/E N/A 
Day Low $3.89    EPS $-0.30 
Volume 25,723